The DRY motif with the highly conserved R3.50 is a hallmark of family A G protein-coupled receptors (GPCRs). The crystal structure of rhodopsin revealed a salt bridge between R135 3.50 and another conserved residue, E247
Introduction
G protein-coupled receptors (GPCRs) represent the largest superfamily of transmembrane receptors in the human genome; 25-50% of all marketed drugs act directly or indirectly via members of this family. Nonetheless, their potential for future drug development is not fully used as a detailed elucidation of GPCR regulatory mechanisms; in particular, their receptor specificity is still lacking (Vassilatis et al., 2003; Jacoby et al., 2006; Overington et al., 2006) . Rhodopsin-like family A GPCRs are characterized by a few highly conserved amino acid motifs ( Fig. 1 ) that are assumed to play a crucial role for structure and/ or function (Nygaard et al., 2009; Salon et al., 2011) . The darkstate crystal structure of bovine rhodopsin (PDB: 1U19) displayed a salt bridge between arginine 3.50 [R3.50, denoted according to the Ballesteros/Weinstein numbering (Ballesteros et al., 1998) ] of the E/DRY motif at the cytosolic end of transmembrane domain 3 (TM3) and glutamate 6.30 (E6.30) in helix 6 (Palczewski et al., 2000) . This interaction is also known as ionic lock and has been reported to maintain the inactive rhodopsin conformation by connecting TM3 and TM6 (Teller et al., 2001; Okada et al., 2004; Vogel et al., 2008) . R3.50 is the most conserved residue in family A GPCRs (96%), in which an acidic residue in position 6.30 is also quite common (32%) (Mirzadegan et al., 2003; Springael et al., 2007) . However, with regard to the latter, there are large differences among subfamilies: it is found in almost all amine GPCRs (.90% E/ D6.30) but occurs rarely in peptide GPCRs (,7%). Of surprise, little information is available on the importance of the ionic lock for the overall activity status in these nonrhodopsin GPCRs. This is mainly attributable to the fact that most investigations focused on R3.50 in the DRY motif instead of on the acidic residue in position 6.30 (Scheer et al., 1996; Ballesteros et al., 1998; Rovati et al., 2007) . R3.50, however, is per se indispensable for G protein activation (Rovati et al., 2007; Schneider et al., 2010) . Therefore, unfortunately, mutation of R3.50 and G protein-mediated processes are not suitable to determine the consequences of a disruption of the ionic lock on the receptor activity status. In contrast, receptor internalization is also an important process of most activated nonrhodopsin GPCRs and has been reported to be G protein independent (Shenoy and Lefkowitz, 2005; Shukla et al., 2011) . Thus, it is astonishing that the impact of a mutation of R3.50 and the disruption of the ionic lock on this important regulatory mechanism has not been investigated yet.
The human bradykinin B 2 receptor (B 2 R) is a member of the family A GPCRs. Moreover, it is one of the very few peptide GPCRs with an acidic glutamate in position 6.30 and, thus, is suited for studying the ionic lock in a nonrhodopsin GPCR. The B 2 R is ubiquitously expressed in almost all cells and tissues and plays an important role in a variety of physiologic processes comprising vasodilatation, edema formation, natriuresis, and hyperalgesia (Leeb-Lundberg et al., 2005) . Its stimulation results in activation of the G proteins G q/11 and G i and of G protein-dependent mitogen-activated protein kinase (MAPK) cascades (Blaukat et al., 2000; Leschner et al., 2011) . Ligand-mediated receptor internalization is important for the regulation of B 2 R signaling. It is initiated by phosphorylation of serine/threonine residues in the B 2 R C terminus, which leads to the recruitment of b-arrestins and ends with the sequestration of the receptor into intracellular compartments (Leeb-Lundberg et al., 2005) .
In recent years, it has become clear that multiple conformations of a single GPCR exist that are coupled in different ways to the various effects controlled by the respective receptor (Rosenbaum et al., 2009; Salon et al., 2011) and may depend on the type of ligand bound. Therefore, we hypothesized that the ionic lock and the surrounding amino acid network might play distinct roles in G protein activation and receptor internalization. We used the B 2 R to test our hypothesis and were able to show for the first time that interruption of the ionic lock differentially affects receptor internalization and G proteinmediated signaling. Moreover, disrupting the ionic lock by mutating only a single amino acid (E6.30) completely altered the impact of several antagonists on these processes. Our findings argue for a multistep process of GPCR activation, in which each step might have a different sensitivity for agonists and antagonists. This new insight into GPCR activation might contribute to a more efficient drug design.
Materials and Methods
Materials. Flp-In TREx-293 (HEK293) cells and Opti-MEM I serum-free medium were obtained from Invitrogen (Karlsruhe, Germany); [2,3-prolyl-3 (1-{4-Methyl-3-[2-methyl-4-(4-methyl-2H-pyrazol-3-yl)-quinolin-8-yloxymethyl]-pyridin-2-ylmethyl}-3-trifluoromethyl-1H-pyridin-2-one) were generous gifts from Dr. L. Gera and J. Stewart (Denver, CO) and Jerini (Berlin, Germany), respectively. Roche (Mannheim, Germany) delivered FuGeneHD, complete mini EDTA-free protease inhibitor tablets and the rat monoclonal anti-hemagglutinin (HA)-peroxidase high-affinity antibody (3F10). EZview red anti-HA affinity gel, poly-D-lysine, captopril, 1,10-phenanthroline, and bacitracin were purchased from Sigma-Aldrich (Taufkirchen, Germany). Fetal calf serum, DMEM, penicillin/streptomycin, and hygromycin B were obtained from PAA Laboratories (Coelbe, Germany). Primers were synthesized by MWG-Biotech (Ebersberg, Germany) and delivered desalted and lyophilized.
Gene Mutagenesis, Expression, and Cell Culture. Standard polymerase chain reactor techniques with accordingly designed primers and the bradykinin B 2 receptor (B 2 R) gene as template were used to generate point-mutants of the B 2 R. The coding sequences of the B 2 Rwt and the mutants started with the third encoded Met (Hess et al., 1992) and were cloned into the HindIII and XhoI sites of the pcDNA5/FRT/TO vector (Invitrogen). At the N terminus, a single hemagglutinin tag (MGYPYDVPDYAGS), with the last two amino acids (Gly-Ser) of the tag deriving from the insertion of a BamHI restriction site, preceded the receptor sequences. For stable, inducible expression of the constructs, we used the Flp-In TREx-293 system from Invitrogen, in which the vector containing the gene of interest is inserted at a unique locus into the genome of the special host cell line through the transient expression of recombinase pOG44. HEK293 cells, cultivated in DMEM supplemented with 10% fetal calf serum and penicillin/streptomycin, were transfected using the transfection reagent FuGeneHD according to the instructions of the manufacturer. Single stably expressing clones resulted from selection with 250 mg/ml hygromycin B. Receptor expression in these cells was induced by addition of 0.5 mg/ml tetracycline 1-2 days before the experiment. For experiments requiring repeated rinsing of the cells, poly-D-lysine-treated (0.01% in phosphate-buffered saline [PBS]) cell culture dishes were used to ensure adherence.
Equilibrium Binding Experiments at 4°C and 37°C. The dissociation constant (K d ) was determined with [ 3 H]BK as described previously (Faussner et al., 2004) . For determination of the equilibrium binding affinity constant at 37°C, receptor sequestration was inhibited by pretreatment of the cells with 100 mM phenylarsine oxide (PAO) for 5 minutes at 37°C (Faussner et al., 2004) . Cell monolayers in 48 wells were incubated either on ice for 90 minutes or at 37°C for 30 minutes in incubation buffer (40 mM PIPES, 109 mM NaCl, 5 mM KCl, 0.1% glucose, 0.05% BSA, 2 mM CaCl 2 , 1 mM MgCl 2 ; pH, 7.4) with degradation inhibitors (2 mM bacitracin, 0.8 mM 1,10-phenanthroline, and 100 mM captopril) containing increasing concentrations of up to 30 nM [ Highly conserved residues are shown as white circles and the one letter code for amino acids in black. The two residues involved in the formation of the ionic lock and residues T6.34 and Arg142 (see Discussion) are depicted in black or gray circles, respectively, with white letters. The Ballesteros/ Weinstein numbering (Ballesteros et al., 1998) has been used for identification of residues. transferred to a scintillation vial, and counted in a b-counter after addition of scintillation fluid. Nonspecific binding was determined with a 1000-fold excess of unlabeled BK and subtracted from total binding to give receptor-specific binding.
[ (Faussner et al., 2012) . Nonspecific binding was determined either with a 1000-fold excess of unlabeled JSM10292 (calculated specific binding comprises intracellular and surface receptors) or BK (calculated specific binding covers only surface receptors). The amount of intracellular receptors is calculated as the difference between specific binding obtained with JSM10292 and that obtained with BK.
Determination of Total Inositol Phosphate Accumulation. Monolayers of stably transfected HEK293 cells on 12 wells were incubated overnight with 0.5 ml complete medium containing 1 mCi/ml [ 3 H]inositol. The cells were washed twice with PBS and preincubated for 90 minutes on ice in incubation buffer supplemented with 50 mM LiCl with or without addition of the indicated concentration(s) of (pseudo)peptide. Stimulation was started by placing the cells in a water bath at 37°C and was continued for 30 minutes. The accumulation of inositol phosphates (IPs) was terminated by exchanging the buffer for 0.75 ml of ice-cold 20 mM formic acid solution. After 30 minutes on ice, another 0.75 ml of formic acid solution, followed by 0.2 ml of a 3% ammonium hydroxide solution, were added. The mixture was applied to AG 1-X8 anion exchange columns (Bio-Rad, Munich, Germany; 2 ml volume). The columns were washed with 1 ml of 1.8% ammonium hydroxide and 9 ml of 60 mM sodium formate/5 mM tetraborate buffer, followed by 0.5 ml of 4 M ammonium formate/0.2 M formic acid. Total IPs were finally eluted in 2 ml of the latter buffer and counted in a bcounter after addition of scintillation liquid.
[ ] Ligand internalization was determined as described recently . In brief, cells on 24-well plates were incubated with 0.2 ml of 2 nM [ 3 H]BK or 2.5 nM [ H] ligand. Biotinylation Protection Assay. Confluent cell monolayers were incubated with 0.3 mg/ml disulfide-cleavable sulfo-NHS-SSBiotin (Pierce) in PBS for 30 minutes at 4°C. After rinsing twice with ice-cold Tris-buffered saline (TBS) to quench the biotinylation reaction, cells were equilibrated in Opti-MEM I (Invitrogen) for 30 minutes at 37°C and further incubated in absence or presence of 10 mM bradykinin or 5 mM icatibant. After rinsing with ice-cold TBS, cells were stripped with 50 mM glutathione, 0.3 M NaCl, 75 mM NaOH, and 1% FCS for 30 minutes at 4°C, wherever indicated. Glutathione was quenched with 50 mM iodoacetamide and 1% BSA for 20 minutes at 4°C. All cells were washed twice with ice-cold PBS and lysed with extraction buffer (pH 7.4) containing 0.1% Triton X-100, 10 mM Tris-HCl, 150 mM NaCl, 25 mM KCl, and a protease inhibitor cocktail (Complete Mini, EDTA-free; Roche, Mannheim, Germany). Lysates were centrifuged for 15 minutes with 14,000 rpm at 4°C in a microcentrifuge. The supernatant was added to 20 ml of EZview red anti-HA affinity gel pre-equilibrated with extraction buffer and incubated under gentle mixing for 1 hour at 4°C. Subsequently, the matrix was washed extensively with extraction buffer and denatured with NuPAGE LDS sample buffer (Invitrogen) for 5 minutes at 95°C without reducing agents. Proteins were fractionated by SDS polyacrylamide gel electrophoresis (PAGE) and transferred to nitrocellulose membranes, which were blocked for 1 hour in TBS containing 1% Tween 20 and 5% milk powder. Biotinylated proteins were detected by the Vectastain avidin-biotinylated enzyme complex immunoperoxidase reagent (Vector Laboratories, Burlingame, CA) and developed with Western blot Chemiluminescence Reagent Plus (PerkinElmer Life and Analytical Sciences) .
Receptor Phosphorylation. Stably transfected cells on 6-well plates were washed twice with phosphate-free DMEM, incubated for 1 hour at 37°C, and labeled with 0.2 mCi/ml [ 32 P]orthophosphate for 1 hour. After 5 minutes of stimulation with 1 mM BK at 37°C, cells were scraped in lysis buffer [10 mM Tris-HCl (pH 7.4), 150 mM NaCl, 25 mM KCl, 0.1% Triton X-100] supplemented with a protease inhibitor cocktail (Complete Mini, EDTA-free; Roche, Mannheim, Germany) and centrifuged at 14,000 rpm for 15 minutes at 4°C. Immunoprecipitation of HA-tagged receptor proteins was performed by incubation of the supernatant with 15 ml of EZview red anti-HA affinity gel for 1 hour at 4°C. After washing the matrix in three steps with ice-cold lysis buffer and addition of 30 ml of 1Â NuPAGE LDS Sample Buffer (Invitrogen) containing 0.1 M DTT, immunocomplexes were dissociated at 95°C for 10 minutes. Proteins were separated as described above on a 4-12% SDS-PAGE gel. Receptor phosphorylation was detected by autoradiography.
Protein Determination. Total protein was quantified using the Micro BCA Protein assay reagent kit from Pierce (Rockford, IL) using BSA as standard.
Homology Modeling. Sequence alignment of the human B 2 R with the bovine rhodopsin performed by ClustalW (Saitou and Nei, 1987; Chenna et al., 2003) showed 19% of identical amino acids and 34% of similar amino acids. In the end of TM3 and the beginning of TM6 with E6.30 238 , 32% of the residues are identical and 47% are similar. The human B 2 R model was obtained by using the homology modeling tool of the Molecular Operating Environment V2010.11 (Chemical Computing Group, Inc.) with the following settings: 10 main chain models each with 3 side chain samples at a temperature of 300 K using the amber99 force field (Wang et al., 2000) were built, resulting in 30 intermediate models with an RMS gradient of 1. Of these 30 models, the final homology model was built by applying refinement protocols with an RMS gradient of 0.5. Subsequently, side chain positions were refined to optimize the protein geometry taking into account typical dihedral angle distributions. Models for mutant B 2 R were generated using the mutation tool of Molecular Operating Environment.
Data Analysis. All experiments were performed at least three times in duplicates or triplicates, and results are given as the mean 6 S.E.M. unless otherwise indicated. Data analysis was performed using GraphPad Prism for Macintosh, Version 4.0c (GraphPad Software, Inc., San Diego, CA).
Results
To determine the biochemical and functional role of the two conserved residues R3.50 and E6.30 in B 2 R regulation, Function of Ionic Lock in Bradykinin B 2 Receptor Activities several receptor mutants were generated: (1) by single mutation of the respective residues in the B 2 Rwt, designated R3.50Â or E6.30Â; (2) by combined charge-neutralizing mutations of both corresponding residues to alanines (R3.50A/E6.30A); and (3) by mutual swapping of the respective amino acids R3.50 and E6.30 (R3.50E/E6.30R). All receptor mutants were stably expressed in HEK293 cells, and their phenotypes were characterized with regard to surface receptor expression, their affinity state at 4°C and 37°C, their capacity to induce PI hydrolysis, basal and ligand-induced internalization, their phosphorylation pattern, and receptor distribution.
Use of Different Promoters to Obtain Comparable Surface Expression. We have shown recently for the B 2 Rwt that high overexpression (. 10 pmol/mg protein under the control of the cytomegalovirus promoter) turned ligands, such as icatibant or B9430, known as antagonists in endogenously B 2 R expressing cells, into partial agonists. These effects were not observed when the B 2 Rwt was expressed at a lower level (,5 pmol/mg protein) as obtained by the P min promoter that consists of only the last 51 nucleotides of the cytomegalovirus promoter ). To ensure comparable surface expression levels (B max ) for wild-type and mutant receptor constructs, mutant receptors with their generally lower surface binding were still expressed under the control of the strong cytomegalovirus promoter. Thus, similar stable expression levels were obtained for all constructs (Table 1) .
Single E6.30 Mutants Display High Affinity States at 37°C. Binding studies at 4°C revealed no significant differences between wild-type and mutant receptor constructs with regard to their binding affinity K d (Table 1) . However, unless respective mutations affect directly the binding site, equilibrium binding with [ 3 H]BK at 4°C in our experience always results in comparable high affinity binding for B 2 R constructs ) and, thus, is not really meaningful for determination of the affinity state. With receptor internalization blocked by pretreatment with 100 mM PAO, it is possible to get valuable information on the affinity state of a construct at 37°C in intact cells by determination of the dissociation rate of [ 3 H]BK. A well described example for a constitutively active B 2 R mutant in a permanent high affinity state is construct N3.35 113 A (Marie et al., 1999) . Accordingly, the [ 3 H]BK dissociation observed for this mutant was much slower than that found for the B 2 Rwt, which shows a strong shift to lower affinity at 37°C (Faussner et al., 2004) Basal and Stimulated PI Hydrolysis. B 2 Rwt responded to challenge with 1 mM BK with a 12-fold increase in the accumulation of total IPs, compared with basal levels (Fig.  3A) . Substitution of R3.50 with small neutral or negatively charged residues, such as alanine, histidine, or glutamate, abolished PI hydrolysis after BK stimulation, highlighting the crucial role of R3.50 for G protein activation also in the B 2 R ( Fig. 3A; Table 1 ). BK stimulation of construct E6.30A, in contrast, resulted in an almost 14-fold higher IP accumulation, compared with basal levels. Because basal phospholipase C b activity was not significantly elevated in E6.30A-expressing cells (Fig. 3A) , this construct was not constitutively active with regard to G protein-mediated signal activity, although it displays a high-affinity state at 37°C ( Fig. 2 ; Table 1 ). However, it has been shown that, in addition to constitutively active receptor mutants, there are constructs that display normal basal activity but give strong responses to weak partial agonists and, therefore, are considered to be semi-active (Ballesteros et al., 2001; Fritze et al., 2003) . In line with the idea of semi-activity, we have shown previously that some B 2 R mutants respond with robust PI hydrolysis to the antagonists icatibant and B9430 . As depicted in Fig. 3A , in E6.30A-and E6.30R-expressing cells, icatibant displayed the same efficacy as BK, suggesting semiactive conformations for these mutants. As demonstrated by the dose-response curves shown in Fig. 3B , all the antagonists, B9430, icatibant, and even the small molecule antagonist JSM10292 (Gibson et al., 2009) , stimulated mutant E6.30R with practically identical potency and efficacy as BK. In cells expressing mutant E6.30A, all the tested antagonists (icatibant and JSM10292) also behaved as agonists, however, with slightly lower potency, compared with the stimulation observed with the agonist BK (Supplemental Fig. 1 ). Thus, mutation of E6.30 to an arginine or to an alanine turned all the tested B 2 R ligands into strong agonists. In contrast, mutation of the two amino acids and potential interaction partners of R3.50 in the DRY motif, D3.49, or Y3.51, to alanines, did not change BK-induced PI hydrolysis , compared with B 2 Rwt (data not shown). Unsurprisingly, mutant R3.50A, which did not respond to BK stimulation, was incapable of generating an IP signal after challenge with the antagonist icatibant, and double substitution of R3.50 and E6.30 with alanines created the same phenotype as the single R3.50A mutation (Fig. 3A) . Of interest, mutual swapping of R3.50 and E6.30 (R3.50E/E6.30R) induced a clear tendency to BK-stimulated PI hydrolysis, which, however, did not turn significant (Fig. 3A) . Negative Charge at Position 3.50 Disturbs B 2 R Internalization. After stimulation with BK, the B 2 R gets rapidly internalized (Leeb-Lundberg et al., 2005) . To functionally characterize the effects of disruption of the ionic lock by mutating either R3.50 or E6.30, changes in [ 3 H]BK uptake were determined over a short period of 30 minutes, for which a similar fate of receptor and ligand can be assumed.
After 10 minutes, B 2 Rwt-expressing cells had internalized almost 90% of the specifically bound [
3 H]BK to acetic acid-resistant compartments (Fig. 4A) . Charge-neutralizing mutation of R3.50 to alanine had no significant negative effect, indicating that G protein activation is not a prerequisite for [ 3 H]BK internalization. Only replacement of the positively charged R3.50 with negatively charged residues, such as glutamate or aspartate, significantly reduced the internalization rate (Fig. 4A) . This was not a direct effect of a negatively charged amino acid in position 3.50 on the internalization mechanism per se, because fast internalization could be rescued by an additional mutation of either D3.49 to an arginine or E6.30 to an alanine or an arginine (Fig. 4C) . Accordingly, the respective single mutations of E6.30 also had no effect on [ 3 H] BK internalization (Fig. 4B) .
R3.50A and E6.30A/R Internalize Antagonist [ 3 H] NPC17331. Charge neutralization or charge reversal of E6.30 resulted in strong PI hydrolysis even in response to B 2 R antagonists (Fig. 3) , indicating a semi-active conformation of these mutants with regard to G protein interaction. 
Function of Ionic Lock in Bradykinin B 2 Receptor Activities
Our next goals were to determine (1) whether this was limited to G protein activation or also the case with regard to receptor internalization and (2) whether this was attributable to interruption of the ionic lock in general or only caused by the point mutation of E6.30. H]NPC17331 could either be attributable to ligand-induced receptor internalization (partial agonist effect) or result from ligand-independent constitutive receptor internalization. To distinguish between these two possibilities, a biotinylation protection assay was performed . Cell surface receptors were labeled at 4°C with a membrane-impermeable biotin derivative containing a disulfide linker. Receptors that had been internalized thereafter at 37°C in a ligand-dependent or independent manner were selectively identified by immunoprecipitation and Western blot analysis. Because of their localization within intracellular compartments as a consequence of endocytosis, their biotin label would have been protected from cleavage by the extracellular treatment with reducing glutathione.
B 2 Rwt was prominently internalized only after BK stimulation (Fig. 6) , demonstrating that B 2 Rwt internalization is strictly dependent on agonist stimulation. Breaking the ionic lock by mutating the single residues to alanines (R3.50A, E6.30A) generated receptors that internalized from the cell surface in a constitutive manner (i.e., in the absence of any agonist). Addition of BK augmented this internalization (significantly for R3.50A, as a tendency only for E6.30A) to a similar level as observed for the B 2 Rwt. Simultaneous mutation of R3.50 and E6.30 to alanines (R3.50A/E6.30A) resulted in a construct showing maximal constitutive internalization that could no longer be increased by addition of BK. Intriguingly, any ionic lock between position 3.50 and position 6.30 is sufficient to keep B 2 R internalization fully agonist dependent, because mutually swapping both residues (R3.50E/E6.30R) completely abolished ligand-independent, constitutive internalization. With regard to receptor internalization, icatibant behaved as a neutral antagonist, because in all cases, it neither enhanced nor inhibited (constitutive) receptor internalization (Fig. 6) .
E6.30 Mutation Significantly Increases Basal Receptor Phosphorylation. According to the widely accepted model of GPCR trafficking, receptor phosphorylation mostly by GPCR kinases (GRKs) is considered to be a major requirement for internalization. Thus, we next investigated whether the ligand-dependent and independent internalization behavior of the various B 2 R constructs is also reflected in their respective phosphorylation patterns.
The B 2 Rwt was basally phosphorylated and reacted to BK stimulation with an ∼3-fold increase in phosphorylation intensity (Fig. 7) , in agreement with previous publications (Blaukat et al., 1996; Blaukat et al., 2001 ). Mutant R3.50A showed a slightly increased basal phosphorylation and was BK sensitive. Compared with BK-induced B 2 Rwt phosphorylation, however, the level of agonist-stimulated R3.50A phosphorylation was almost 40% significantly lower (P , 0.05) (Fig. 7B) . Charge-neutralizing substitution of E6.30 with alanine significantly intensified basal receptor phosphorylation by almost 30%, compared with the B 2 Rwt; however, BK treatment further increased phosphorylation. In contrast, charge-neutralizing mutation of both residues (R3.50A/E6.30A) resulted in the strongest basal phosphorylation observed for all constructs, which could also no longer be significantly augmented by addition of BK. Mutual swapping of R3.50 and E6.30 (R3.50E/ E6.30R; i.e., generation of an inverse ionic lock) almost completely reconstituted the B 2 Rwt-like phosphorylation pattern with lower basal phosphorylation and strong additional phosphorylation after stimulation with BK.
When analyzing receptor phosphorylation (Fig. 7) , the B 2 Rwt was also expressed under the control of the strong cytomegalovirus promoter, resulting in elevated expression levels of ∼10 pmol/mg protein. Comparing receptor expression levels from whole cell lysates after immunoprecipitation (Fig.  7A) , no remarkable differences between B 2 Rwt (with 10 pmol) and mutant constructs were detected, conversely to the results obtained from [ 3 H]BK binding experiments, which indicated much lower (cell surface) expression levels for the mutant receptor constructs (Table 1 ). This discrepancy between surface binding data and results from Western blot analysis suggested that mutant receptor constructs might also be located intracellularly (e.g., as a result of constitutive internalization).
Double Mutant R3.50A/E6.30A Is Largely Located Intracellularly. We previously characterized a novel cell membrane-permeant small molecule, JSM10292, which, 3 Hlabeled, allows the differentiation between surface and intracellularly located wild-type and mutant B 2 Rs, as long as they are binding competent (Faussner et al., 2012) . Unlike the B 2 Rwt, which, unstimulated, is located mostly at the cell surface (∼80%), .50% of the single mutant receptor constructs R3.50A and E6.30A were found to be located intracellularly (Table 2) . Strikingly, double mutation of both residues to alanines (R3.50A/E6.30A) lead to a strong intracellular localization of about 70%, whereas mutual exchange of both highly conserved residues (R3.50E/E6.30R) generated a wild-type-like surface localization (Table 2) . Fig. 6 . Receptor internalization determined by biotinylation protection assay. (A) HEK293 cells stably expressing the indicated N-terminally HA-tagged constructs were labeled at 4°C with biotin reagent containing a reducible disulfide linker. Cells were either stripped directly with 50 mM glutathione at 4°C (Strip), or incubated in the absence (2) or presence of 10 mM BK or 5 mM icatibant (icat.) for 1 hour at 37°C and then stripped at 4°C. Immunoprecipitation of receptors and detection of their biotinylation status by Western blot analysis was performed as described in Materials and Methods. The blots shown are representative for three experiments. (B) biotinylated receptors were quantified with ImageJ as described in Materials and Methods and normalized to the amount of biotinylated receptors obtained after BK stimulation that served as a reference for maximal response (= 100%). (One-way ANOVA with Newman-Keuls Multiple Comparison Test: ***P , 0.001).
Function of Ionic Lock in Bradykinin B 2 Receptor Activities Discussion
Homology modeling of the B 2 R, based on the bovine rhodopsin structure as a template, displayed a salt bridge between R3.50 and E6.30 that connects TM3 with TM6 (Fig.  8A) , thus stabilizing the inactive conformation. An additional network of hydrogen bonds around R3.50 and E6.30, involving the side chains of D3.49 and T6.34 and the carbonyl oxygens of A6.33 and E6.30, supports the ionic lock in this B 2 R model. All these residues can be found in identical positions in many other family A GPCRs, suggesting similar structural networks.
Function of the DRY Motif with R3.50
In the B 2 R, a single substitution of R3.50 with other amino acids (A, H, D, E) completely abolished the receptor's ability to induce PI hydrolysis (Table 1) , arachidonic acid release (shown for R3.50A; Supplemental Fig. 2) , and ERK1/2 phosphorylation (Supplemental Fig. 3 ). This emphasizes the significance of this residue for productive G protein interaction, which has also been observed for almost all other family A GPCRs investigated thus far (Scheer et al., 1996; Ballesteros et al., 2001 ).
For GPCRs that become phosphorylated by GRK2/3 during their desensitization, it has been proposed that these GRKs are recruited by attaching with their pleckstrin homology domains to bg-subunits that become available after G protein activation (Willets et al., 2003) . This mechanism is obviously not the only plausible one, because all signaling-incompetent R3.50 mutants were phosphorylated (shown for R3.50A; Fig.  7 ) and internalized similarly to the B 2 Rwt (Fig. 4) . Fast internalization has also been reported for a G protein activation-incompetent R3.50A mutant of the type 1 angiotensin receptor (AT 1 R) (Gaborik et al., 2003) . Disruption of the ionic bond might therefore result in a conformation that directly interacts with GRK2/3. Such a direct interaction that was primarily dependent on an intact helix 8 of the receptor has been demonstrated for wild-type and truncated B 2 R constructs .
GPCRs can activate MAPK cascades G protein dependently and/or via the recruitment of b-arrestins (Shenoy and Lefkowitz, 2005) . Our data support a predominantly G protein-dependent MAPK activation by the B 2 R, because the PI hydrolysis-incompetent mutant R3.50A becomes internalized rapidly after BK stimulation (Fig. 4 ) and, therefore, should interact with b-arrestins (as also indicated by translocation studies with eYFP-b-arrestin 1 and 2; data not shown) but, nevertheless, does not induce ERK1/2 phosphorylation (Supplemental Fig. 3 ). In contrast, the AT 1 R DRY mutant was still able to elicit ERK1/2 phosphorylation in a b-arrestindependent way, as demonstrated by siRNA-knockdown experiments (Wei et al., 2003) . Thus, whether an interaction with b-arrestins results not only in internalizaltion but also in ERK1/2 activation might depend on additional factors (e.g., a receptor-specific GRK-generated phosphorylation pattern) (Nobles et al., 2011) .
Although for other GPCRs, residue D3.49 was reported to play an important role in G protein-dependent signaling (Scheer et al., 1996; Rasmussen et al., 1999) , we did not observe any significant differences between mutant D3.49A and the B 2 Rwt with regard to PI hydrolysis, ligand-mediated internalization, or affinity state at 37°C (data not shown). This stresses the importance of the structural context of these highly conserved residues, because they apparently not do play necessarily the same roles in different family A GPCRs.
Function of E6.30 in the Activation Process
Charge neutralization or reversal of E6.30 resulted in B 2 R constructs that responded with strong PI hydrolysis and ERK1/2 phosphorylation (Supplemental Fig. 3 ; not shown for E6.30R) not only to the agonist BK, but also to the antagonists B9430, icatibant, or JSM10292 ( Fig. 3; Supplemental Fig. 1 ). Contrary to the b 2 -adrenergic receptor, where E6.30A mutation elevated basal receptor activity (Ballesteros et al., 2001) , or the 5-hydroxytryptamine 2A (5-HT2A) receptor, in which E6.30R mutation evoked a high constitutive activity (Shapiro et al., 2002) , the analog B 2 R mutants showed no or only minor increases in basal IP generation (Fig. 3) or MAPK stimulation (Supplemental Fig. 3 ). However, they apparently adapted a highly sensitive conformation, as also indicated by their high affinity state at 37°C ( Fig. 2; Table 1 ), that could be easily activated by binding of all kinds of ligands. The data also demonstrate that a high affinity state of a GPCR does not necessarily imply constitutive activity. Similarly, E6.30 mutations in the thromboxane prostanoid receptor resulted in more efficient agonist-induced signaling without any increase in basal activity (Ambrosio et al., 2010) . Moreover, for the B 2 R, even the small molecule compound JSM10292, which thus far had displayed no partial agonistic activity (Faussner et al., 2012) , becomes a full agonist in mutant E6.30R. This might be explained by assuming a semi-active conformation due to repulsion of the two positively charged arginines (Fig. 8C ) that imitates in a way a structural change-TM6 moving away from TM3-that has been described as part of the activation process (Ballesteros et al., 2001; Springael et al., 2007; Rasmussen et al., 2011) . In addition, mutation E6.30A/R resulted in strong uptake of the antagonist [ 3 H] NPC17331, increased basal phosphorylation, constitutive internalization, and consequently, considerable intracellular localization. These data strengthen the idea that the E6.30 mutants adopt a conformation that constitutively interacts with GRKs and b-arrestins, but not with G proteins, because they display no significant agonist-independent PI hydrolysis.
Is There an Ionic Lock in the B 2 R? . Although homology modeling indicated an ionic lock (Fig. 8A ) in the B 2 R, its presence would set the B 2 R apart from other peptide GPCRs, because most of them (.90%) cannot form an ionic lock because of the lack of an acidic residue in position 6.30 (Mirzadegan et al., 2003 Function of Ionic Lock in Bradykinin B 2 Receptor Activities interacting, effects of single mutations should be rather different and, in most cases, additive in the double mutant. In contrast, if they form an ionic lock, the effects of the single mutations, in theory, should give identical results. Both mutants R3.50A and E6.30A internalized the antagonist [ 3 H] NPC17331, both indicated constitutive internalization that could be increased by BK but not icatibant, and both showed elevated basal phosphorylation and similar intracellular localization. Because the double mutation R3.50A/E6.30A resulted in effects that were at least as strong as those of the single mutations, but not significantly higher or additive, the formation of an ionic lock in the B 2 R in its inactive state is feasible. The fact that all the observed effects were stronger in the E6.30 mutants than in mutant R3.50A might be explained by residue Arg142 in the second intracellular loop acting as a compensatory interaction partner for E6.30 (Fig. 8B) . The strongest indication for an ionic bond in the B 2 R is the rescue of wild-type behavior by swapping the respective arginine and glutamate (R3.50E/E6.30R), thus generating an inverse ionic lock (Fig. 8D) . 5-HT2A receptor activation seems to follow a similar pattern, because analog swapping of residues 3.50 and 6.30 abolished an increase in basal receptor signaling activity (Shapiro et al., 2002) . With regard to basal phosphorylation and constitutive internalization, however, a clear trend toward an additive effect was seen in the double mutant (e.g., the intracellular localization), suggesting that both residues function also via other interaction partners outside the ionic bond. The importance of the respective microenvironment of R3.50 and E6.30 is also indicated by a report that the constitutive activity of the human histamine H 4 receptor, which contains an alanine in position 6.30, cannot be simply reduced by reconstituting an ionic lock generating a mutant A6.30E (Schneider et al., 2010) .
Conclusions
Our results indicate that, in the inactive B 2 R, R3.50 and E6.30 form an ionic lock. We show for the first time that the ionic lock in a family A GPCR can play different roles when comparing G protein activation with the interaction with GRKs and arrestins in the process of receptor internalization. Its disruption in the B 2 R resulted in constitutive internalization with consequently strong intracellular localization of the constructs, but did not change the character of the tested B 2 R antagonists in this regard. In contrast, mutation of E6.30 did not result in constitutive G protein activation but turned all tested B 2 R antagonists into strong agonists. This suggests a multistep process of B 2 R activation, in which the disruption of the salt bridge between R3.50 and E6.30 plays a pivotal but differential role with regard to the different processes of G protein activation and receptor internalization. Thus, our findings strengthen current concepts of biased agonism and functional selectivity. Different ligand-induced conformational changes and subsequent signaling has also been suggested for several GPCRs (Ahn et al., 2004; Kobilka and Deupi, 2007; Rosenbaum et al., 2009) , highlighting the structural flexibility of GPCRs and the dynamic nature of their activation process. Similarly, multiple structurally different ligands are known to stabilize distinct conformational states of the b 2 -adrenergic receptor, eliciting differential cellular responses (Bhattacharya et al., 2008; Kahsai et al., 2011) . Deeper insight into the multistep mechanism of GPCR activation, as provided by our study, and the generation of differentially active mutants might help in the development and screening of new specific biased agonists and antagonists for optimized therapeutic intervention.
